Oman Medical Journal published new progress about 15029-36-4. 15029-36-4 belongs to amides-buliding-blocks, auxiliary class Nitrile,Amine,Aliphatic hydrocarbon chain,Amide, name is 2-Cyano-N-ethylacetamide, and the molecular formula is C6H5BN2O3, Related Products of amides-buliding-blocks.
Viswanatha, Gollapalle L. published the artcileSynthesis and anti-hyperlipidemic activity of 3H-benzo[4,5]thieno[2,3-d][1,2,3]triazin-4-ones: possible mechanism of altered lipid metabolism, Related Products of amides-buliding-blocks, the publication is Oman Medical Journal (2012), 27(5), 388-395, database is CAplus and MEDLINE.
Objectives: The present study aimed to evaluate the anti-hyperlipidemic activity of newly synthesized tricyclic benzothieno[1,2,3]triazine derivatives I (R = Me, Et, 2-chlorophenyl), namely CP-1 (3-methyl-5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-d][1,2,3]triazin-4-one), CP-2 (3-ethyl-5,6,7,8-tetrahydro-3H-benzo[4,5] thieno[2,3-d][1,2,3]triazin-4-one) and CP-6 [3-(2-chlorophenyl)-5,6,7,8-tetrahydro-3H-benzo[4,5]thieno[2,3-d][1,2,3]triazin-4-one] against dexamethasone and Triton WR-1339-induced hyperlipidemia in rats. Methods: Anti-hyperlipidemic activities of the test compounds were evaluated against dexamethasone (10 mg/kg, s.c. [s.c.]) and Triton WR-1339 (200 mg/kg, i.p. [i.p]) induced hyperlipidemia in rats. Results: Administration of a single dose of Triton WR-1339 (200 mg/kg i.p) and dexamethasone (10 mg/kg s.c.) for 8 consecutive days to adult wistar rats caused severe hyperlipidemia characterized by a marked increase in serum cholesterol, LDL-C, VLDL-C and triglyceride levels along with an increase in atherogenic index. Serum HDL-C levels were decreased significantly compared to a normal control. Pretreatment with Atorvastatin (10 mg/kg p.o.), CP-1 (25 and 50 mg/kg), CP-2 (25 and 50 mg/kg) and CP-6 (25 and 50 mg/kg) showed significant and dose-dependent protection against dexamethasone and Triton WR-1339-induced hyperlipidemia in rats by maintaining serum total cholesterol, LDL-C, VLDL-C and HDL-C levels within the normal range. Also, a significant decrease in the atherogenic index was observed The anti-hyperlipidemic effect of CP-6 was comparable with reference standard Atorvastatin. Furthermore, CP-6 was found to be more potent than CP-1 and CP-2. Conclusion: These findings suggest that CP-1, CP-2 and CP-6 possess significant anti-hyperlipidemic activity against exptl. animal models of hyperlipidemia.
Oman Medical Journal published new progress about 15029-36-4. 15029-36-4 belongs to amides-buliding-blocks, auxiliary class Nitrile,Amine,Aliphatic hydrocarbon chain,Amide, name is 2-Cyano-N-ethylacetamide, and the molecular formula is C6H5BN2O3, Related Products of amides-buliding-blocks.
Referemce:
https://en.wikipedia.org/wiki/Amide,
Amide – an overview | ScienceDirect Topics